Cargando…
CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600828/ https://www.ncbi.nlm.nih.gov/pubmed/37882317 http://dx.doi.org/10.1002/ctm2.1459 |
| _version_ | 1785126071048339456 |
|---|---|
| author | Li, Shijia Ge, Jianrong Zhou, Shiyuan Zhu, Wenjuan Han, Yue Chen, Suning Xue, Shengli Wang, Ying Qiu, Huiying Wu, Xiaojin Wu, Depei |
| author_facet | Li, Shijia Ge, Jianrong Zhou, Shiyuan Zhu, Wenjuan Han, Yue Chen, Suning Xue, Shengli Wang, Ying Qiu, Huiying Wu, Xiaojin Wu, Depei |
| author_sort | Li, Shijia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10600828 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106008282023-10-27 CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation Li, Shijia Ge, Jianrong Zhou, Shiyuan Zhu, Wenjuan Han, Yue Chen, Suning Xue, Shengli Wang, Ying Qiu, Huiying Wu, Xiaojin Wu, Depei Clin Transl Med Letter to the Journal John Wiley and Sons Inc. 2023-10-26 /pmc/articles/PMC10600828/ /pubmed/37882317 http://dx.doi.org/10.1002/ctm2.1459 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Journal Li, Shijia Ge, Jianrong Zhou, Shiyuan Zhu, Wenjuan Han, Yue Chen, Suning Xue, Shengli Wang, Ying Qiu, Huiying Wu, Xiaojin Wu, Depei CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title | CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title_full | CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title_fullStr | CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title_full_unstemmed | CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title_short | CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation |
| title_sort | cd19/cd22 dual‐targeting chimeric antigen receptor t‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for b‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and epstein–barr virus viremia after transplantation |
| topic | Letter to the Journal |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600828/ https://www.ncbi.nlm.nih.gov/pubmed/37882317 http://dx.doi.org/10.1002/ctm2.1459 |
| work_keys_str_mv | AT lishijia cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT gejianrong cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT zhoushiyuan cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT zhuwenjuan cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT hanyue cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT chensuning cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT xueshengli cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT wangying cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT qiuhuiying cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT wuxiaojin cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation AT wudepei cd19cd22dualtargetingchimericantigenreceptortcelltherapybridgingtoallogeneichaematopoieticstemcelltransplantationforbcellacutelymphoblasticleukaemiadelaysplateletrecoveryandincreasesrisksofcytomegalovirusandepsteinbarrvirusviremiaaftertransplantation |